Epigenetics Drugs & Diagnostic Technologies Market - Global Outlook and Forecast 2022-2028

February 2022 | 60 pages | ID: ED573CA4CA6CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Epigenetics Drugs & Diagnostic Technologies in Global, including the following market information:

Global Epigenetics Drugs & Diagnostic Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Epigenetics Drugs & Diagnostic Technologies market was valued at 9268.1 million in 2021 and is projected to reach US$ 26730 million by 2028, at a CAGR of 16.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Epigenetics Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Epigenetics Drugs & Diagnostic Technologies include 4SC, Acetylon Pharmaceuticals, Astex Pharmaceuticals, CellCentric, Celleron Therapeutics, Celgene Corporation, Chroma Therapeutics, Epigentek Group and Eisai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenetics Drugs & Diagnostic Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epigenetics Drugs & Diagnostic Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Epigenetics Drugs & Diagnostic Technologies Market Segment Percentages, by Type, 2021 (%)

• Epigenetics Drugs
• Epigenetics Diagnostic Technologies

Global Epigenetics Drugs & Diagnostic Technologies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Epigenetics Drugs & Diagnostic Technologies Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Research Institution
• Others

Global Epigenetics Drugs & Diagnostic Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Epigenetics Drugs & Diagnostic Technologies Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Epigenetics Drugs & Diagnostic Technologies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Epigenetics Drugs & Diagnostic Technologies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 4SC
• Acetylon Pharmaceuticals
• Astex Pharmaceuticals
• CellCentric
• Celleron Therapeutics
• Celgene Corporation
• Chroma Therapeutics
• Epigentek Group
• Eisai
• EnVivo Pharmaceuticals
• Base Genomics
• Oryzon Genomics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Epigenetics Drugs & Diagnostic Technologies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Epigenetics Drugs & Diagnostic Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPIGENETICS DRUGS & DIAGNOSTIC TECHNOLOGIES OVERALL MARKET SIZE

2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Size: 2021 VS 2028
2.2 Global Epigenetics Drugs & Diagnostic Technologies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Epigenetics Drugs & Diagnostic Technologies Players in Global Market
3.2 Top Global Epigenetics Drugs & Diagnostic Technologies Companies Ranked by Revenue
3.3 Global Epigenetics Drugs & Diagnostic Technologies Revenue by Companies
3.4 Top 3 and Top 5 Epigenetics Drugs & Diagnostic Technologies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Epigenetics Drugs & Diagnostic Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epigenetics Drugs & Diagnostic Technologies Players in Global Market
  3.6.1 List of Global Tier 1 Epigenetics Drugs & Diagnostic Technologies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Epigenetics Drugs & Diagnostic Technologies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Epigenetics Drugs & Diagnostic Technologies Market Size Markets, 2021 & 2028
  4.1.2 Epigenetics Drugs
  4.1.3 Epigenetics Diagnostic Technologies
4.2 By Type - Global Epigenetics Drugs & Diagnostic Technologies Revenue & Forecasts
  4.2.1 By Type - Global Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2022
  4.2.2 By Type - Global Epigenetics Drugs & Diagnostic Technologies Revenue, 2023-2028
  4.2.3 By Type - Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Epigenetics Drugs & Diagnostic Technologies Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Research Institution
  5.1.4 Others
5.2 By Application - Global Epigenetics Drugs & Diagnostic Technologies Revenue & Forecasts
  5.2.1 By Application - Global Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2022
  5.2.2 By Application - Global Epigenetics Drugs & Diagnostic Technologies Revenue, 2023-2028
  5.2.3 By Application - Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Epigenetics Drugs & Diagnostic Technologies Market Size, 2021 & 2028
6.2 By Region - Global Epigenetics Drugs & Diagnostic Technologies Revenue & Forecasts
  6.2.1 By Region - Global Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2022
  6.2.2 By Region - Global Epigenetics Drugs & Diagnostic Technologies Revenue, 2023-2028
  6.2.3 By Region - Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2028
  6.3.2 US Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.3.3 Canada Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.3.4 Mexico Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2028
  6.4.2 Germany Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.4.3 France Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.4.4 U.K. Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.4.5 Italy Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.4.6 Russia Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.4.7 Nordic Countries Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.4.8 Benelux Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2028
  6.5.2 China Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.5.3 Japan Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.5.4 South Korea Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.5.5 Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.5.6 India Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2028
  6.6.2 Brazil Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.6.3 Argentina Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2028
  6.7.2 Turkey Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.7.3 Israel Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.7.4 Saudi Arabia Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028
  6.7.5 UAE Epigenetics Drugs & Diagnostic Technologies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 4SC
  7.1.1 4SC Corporate Summary
  7.1.2 4SC Business Overview
  7.1.3 4SC Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.1.4 4SC Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.1.5 4SC Key News
7.2 Acetylon Pharmaceuticals
  7.2.1 Acetylon Pharmaceuticals Corporate Summary
  7.2.2 Acetylon Pharmaceuticals Business Overview
  7.2.3 Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.2.4 Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.2.5 Acetylon Pharmaceuticals Key News
7.3 Astex Pharmaceuticals
  7.3.1 Astex Pharmaceuticals Corporate Summary
  7.3.2 Astex Pharmaceuticals Business Overview
  7.3.3 Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.3.4 Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.3.5 Astex Pharmaceuticals Key News
7.4 CellCentric
  7.4.1 CellCentric Corporate Summary
  7.4.2 CellCentric Business Overview
  7.4.3 CellCentric Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.4.4 CellCentric Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.4.5 CellCentric Key News
7.5 Celleron Therapeutics
  7.5.1 Celleron Therapeutics Corporate Summary
  7.5.2 Celleron Therapeutics Business Overview
  7.5.3 Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.5.4 Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.5.5 Celleron Therapeutics Key News
7.6 Celgene Corporation
  7.6.1 Celgene Corporation Corporate Summary
  7.6.2 Celgene Corporation Business Overview
  7.6.3 Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.6.4 Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.6.5 Celgene Corporation Key News
7.7 Chroma Therapeutics
  7.7.1 Chroma Therapeutics Corporate Summary
  7.7.2 Chroma Therapeutics Business Overview
  7.7.3 Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.7.4 Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.7.5 Chroma Therapeutics Key News
7.8 Epigentek Group
  7.8.1 Epigentek Group Corporate Summary
  7.8.2 Epigentek Group Business Overview
  7.8.3 Epigentek Group Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.8.4 Epigentek Group Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.8.5 Epigentek Group Key News
7.9 Eisai
  7.9.1 Eisai Corporate Summary
  7.9.2 Eisai Business Overview
  7.9.3 Eisai Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.9.4 Eisai Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.9.5 Eisai Key News
7.10 EnVivo Pharmaceuticals
  7.10.1 EnVivo Pharmaceuticals Corporate Summary
  7.10.2 EnVivo Pharmaceuticals Business Overview
  7.10.3 EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.10.4 EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.10.5 EnVivo Pharmaceuticals Key News
7.11 Base Genomics
  7.11.1 Base Genomics Corporate Summary
  7.11.2 Base Genomics Business Overview
  7.11.3 Base Genomics Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.11.4 Base Genomics Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.11.5 Base Genomics Key News
7.12 Oryzon Genomics
  7.12.1 Oryzon Genomics Corporate Summary
  7.12.2 Oryzon Genomics Business Overview
  7.12.3 Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Major Product Offerings
  7.12.4 Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Revenue in Global Market (2017-2022)
  7.12.5 Oryzon Genomics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Epigenetics Drugs & Diagnostic Technologies Market Opportunities & Trends in Global Market
Table 2. Epigenetics Drugs & Diagnostic Technologies Market Drivers in Global Market
Table 3. Epigenetics Drugs & Diagnostic Technologies Market Restraints in Global Market
Table 4. Key Players of Epigenetics Drugs & Diagnostic Technologies in Global Market
Table 5. Top Epigenetics Drugs & Diagnostic Technologies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Epigenetics Drugs & Diagnostic Technologies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Epigenetics Drugs & Diagnostic Technologies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Epigenetics Drugs & Diagnostic Technologies Product Type
Table 9. List of Global Tier 1 Epigenetics Drugs & Diagnostic Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epigenetics Drugs & Diagnostic Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Epigenetics Drugs & Diagnostic Technologies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Epigenetics Drugs & Diagnostic Technologies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Epigenetics Drugs & Diagnostic Technologies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Epigenetics Drugs & Diagnostic Technologies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 30. 4SC Corporate Summary
Table 31. 4SC Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 32. 4SC Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 33. Acetylon Pharmaceuticals Corporate Summary
Table 34. Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 35. Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 36. Astex Pharmaceuticals Corporate Summary
Table 37. Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 38. Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 39. CellCentric Corporate Summary
Table 40. CellCentric Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 41. CellCentric Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 42. Celleron Therapeutics Corporate Summary
Table 43. Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 44. Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 45. Celgene Corporation Corporate Summary
Table 46. Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 47. Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 48. Chroma Therapeutics Corporate Summary
Table 49. Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 50. Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 51. Epigentek Group Corporate Summary
Table 52. Epigentek Group Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 53. Epigentek Group Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 54. Eisai Corporate Summary
Table 55. Eisai Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 56. Eisai Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 57. EnVivo Pharmaceuticals Corporate Summary
Table 58. EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 59. EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 60. Base Genomics Corporate Summary
Table 61. Base Genomics Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 62. Base Genomics Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 63. Oryzon Genomics Corporate Summary
Table 64. Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Product Offerings
Table 65. Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Epigenetics Drugs & Diagnostic Technologies Segment by Type in 2021
Figure 2. Epigenetics Drugs & Diagnostic Technologies Segment by Application in 2021
Figure 3. Global Epigenetics Drugs & Diagnostic Technologies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Epigenetics Drugs & Diagnostic Technologies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Epigenetics Drugs & Diagnostic Technologies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue in 2021
Figure 8. By Type - Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 12. US Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 16. Germany Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 17. France Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 24. China Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 28. India Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 30. Brazil Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 33. Turkey Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Epigenetics Drugs & Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 37. 4SC Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. CellCentric Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Epigentek Group Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eisai Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Base Genomics Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)